ArticlePolymers2026
Enhanced Multifunctional Properties of Bipyridyl-Containing Polyurethane Nanocomposites Reinforced with Graphene/ZnO Hybrid Fillers.
Article in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A series of polyurethane (PU) nanocomposites incorporating 4,4'-bis(hydroxymethyl)-2,2'-bipyridine (BBD) as a chain extender and a commercially supplied graphene/zinc oxide (G/ZnO) hybrid filler were successfully synthesized. The effects of G/ZnO loading (0-2.0 wt.%) on the structural, thermal, mechanical, surface-wettability, and antibacterial properties of the nanocomposites were systematically investigated. Fourier-transform infrared spectroscopy confirmed the formation of the polyurethane structure and revealed changes in characteristic absorption bands following G/ZnO incorporation. Morphological observation of the pristine G/ZnO hybrid filler revealed an irregular and aggregated morphology, while X-ray diffraction confirmed the presence of crystalline ZnO. Energy-dispersive X-ray spectroscopy and elemental mapping showed Zn-containing regions within the examined areas of the G/ZnO-containing PU samples. X-ray photoelectron spectroscopy further confirmed the surface presence of Zn-containing species, with the Zn atomic concentration increasing from 0 at.% in PU-01 to 0.82 at.% in PU-04. Thermogravimetric analysis showed modest changes in thermal decomposition behavior with increasing G/ZnO loading, while differential scanning calorimetry and dynamic mechanical analysis revealed shifts in glass-transition and relaxation behavior, consistent with changes in polymer-chain mobility and the local interfacial environment. The tensile strength increased from 2.68 MPa for neat PU to 11.76 MPa for the nanocomposite containing 2.0 wt.% G/ZnO, accompanied by an increase in Young's modulus. The water contact angle increased from approximately 68° to 89°, indicating reduced apparent surface wettability with increasing G/ZnO loading. The nanocomposites also exhibited antibacterial activity against Escherichia coli and Staphylococcus aureus, with antibacterial efficiencies exceeding 95% at higher G/ZnO loadings. Overall, the incorporation of the commercial G/ZnO hybrid filler was associated with changes in the thermal, mechanical, surface, and antibacterial properties of the BBD-containing PU system. Because separate PU systems without BBD and individual graphene- and ZnO-containing controls were not included, the individual contributions of BBD, graphene, and ZnO, as well as any synergistic effect between graphene and ZnO, cannot be established from the present results. Further studies addressing filler leaching, long-term antibacterial stability, coating adhesion, environmental durability, and cytocompatibility are required to establish the practical applicability of these materials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.